Ostarijas E, Onyema M, Zair Z, Taylor D, Lajeunesse-Trempe F, Reynolds S
Endocr Relat Cancer. 2025; 32(4).
PMID: 39985422
PMC: 11906127.
DOI: 10.1530/ERC-24-0200.
Ghesmati Z, Rashid M, Fayezi S, Gieseler F, Alizadeh E, Darabi M
Rev Endocr Metab Disord. 2023; 25(2):279-308.
PMID: 38051471
PMC: 10942928.
DOI: 10.1007/s11154-023-09850-0.
Marzan A, Chitti S
Cells. 2023; 12(22).
PMID: 37998333
PMC: 10670053.
DOI: 10.3390/cells12222598.
Jalloul W, Moscalu M, Moscalu R, Jalloul D, Grierosu I, Ionescu T
Curr Issues Mol Biol. 2023; 45(10):7891-7914.
PMID: 37886942
PMC: 10604972.
DOI: 10.3390/cimb45100499.
Inoue T, Fu B, Nishio M, Tanaka M, Kato H, Tanaka M
Nutrients. 2023; 15(2).
PMID: 36678220
PMC: 9865844.
DOI: 10.3390/nu15020350.
Primary Tumor Fluorine-18 Fluorodeoxydglucose (F-FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse Survival.
Olaechea S, Gannavarapu B, Alvarez C, Gilmore A, Sarver B, Xie D
Front Oncol. 2022; 12:900712.
PMID: 35814438
PMC: 9263563.
DOI: 10.3389/fonc.2022.900712.
Chronic Inflammation in Obesity and Cancer Cachexia.
Divella R, Gadaleta Caldarola G, Mazzocca A
J Clin Med. 2022; 11(8).
PMID: 35456284
PMC: 9027625.
DOI: 10.3390/jcm11082191.
Determining the factors affecting energy metabolism and energy requirement in cancer patients.
Bulmus Tuccar T, Tek N
J Res Med Sci. 2022; 26:124.
PMID: 35126587
PMC: 8772515.
DOI: 10.4103/jrms.JRMS_844_20.
High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Li Q, Zhang L, Hou Z, Zhao D, Li J, Zhang S
Front Cell Dev Biol. 2021; 9:710104.
PMID: 34568324
PMC: 8455878.
DOI: 10.3389/fcell.2021.710104.
Adaptive thermogenesis in brown adipose tissue involves activation of pannexin-1 channels.
Senthivinayagam S, Serbulea V, Upchurch C, Polanowska-Grabowska R, Mendu S, Sahu S
Mol Metab. 2020; 44:101130.
PMID: 33248294
PMC: 7779784.
DOI: 10.1016/j.molmet.2020.101130.
The Remaining Mysteries about Brown Adipose Tissues.
Nishio M, Saeki K
Cells. 2020; 9(11).
PMID: 33182625
PMC: 7696203.
DOI: 10.3390/cells9112449.
Brown fat does not cause cachexia in cancer patients: A large retrospective longitudinal FDG-PET/CT cohort study.
Becker A, Zellweger C, Bacanovic S, Franckenberg S, Nagel H, Frick L
PLoS One. 2020; 15(10):e0239990.
PMID: 33031379
PMC: 7544086.
DOI: 10.1371/journal.pone.0239990.
Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and Cachexia.
Zwickl H, Hackner K, Kofeler H, Krzizek E, Muqaku B, Pils D
Front Oncol. 2020; 10:1262.
PMID: 32850383
PMC: 7417624.
DOI: 10.3389/fonc.2020.01262.
Vitamin D ameliorates adipose browning in chronic kidney disease cachexia.
Cheung W, Ding W, Hoffman H, Wang Z, Hao S, Zheng R
Sci Rep. 2020; 10(1):14175.
PMID: 32843714
PMC: 7447759.
DOI: 10.1038/s41598-020-70190-z.
The impact of exercise training on adipose tissue remodelling in cancer cachexia.
Ferreira R, Nogueira-Ferreira R, Vitorino R, Santos L, Moreira-Goncalves D
Porto Biomed J. 2020; 2(6):333-339.
PMID: 32258790
PMC: 6806758.
DOI: 10.1016/j.pbj.2017.02.006.
Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives.
Zwickl H, Zwickl-Traxler E, Pecherstorfer M
Front Oncol. 2020; 9:1409.
PMID: 31921666
PMC: 6933599.
DOI: 10.3389/fonc.2019.01409.
Energy metabolism in cachexia.
Rohm M, Zeigerer A, Machado J, Herzig S
EMBO Rep. 2019; 20(4).
PMID: 30890538
PMC: 6446208.
DOI: 10.15252/embr.201847258.
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N, Vandeputte C, Ameye L, Van Bogaert C, Krygier J, Guiot T
BMC Cancer. 2019; 19(1):134.
PMID: 30744591
PMC: 6371452.
DOI: 10.1186/s12885-019-5319-8.
Brown Adipose Tissue Energy Metabolism in Humans.
Carpentier A, Blondin D, Virtanen K, Richard D, Haman F, Turcotte E
Front Endocrinol (Lausanne). 2018; 9:447.
PMID: 30131768
PMC: 6090055.
DOI: 10.3389/fendo.2018.00447.
Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients.
Doles J, Hogan K, OConnor J, Wahner Hendrickson A, Huston O, Jatoi A
J Palliat Med. 2018; 21(9):1334-1338.
PMID: 29792535
PMC: 6154444.
DOI: 10.1089/jpm.2018.0023.